What type of test is used for diagnosing trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Trichomoniasis

Nucleic acid amplification testing (NAAT) is the preferred diagnostic test for trichomoniasis, offering superior sensitivity (95-100%) compared to all other methods and accepting multiple specimen types including vaginal swabs, endocervical swabs, urine, and liquid-based cytology specimens. 1

Primary Diagnostic Method: NAAT

  • NAAT should be used as the first-line diagnostic test when available, as recommended by the CDC, because it provides the highest sensitivity and does not require viable organisms for detection 1
  • The FDA-cleared APTIMA Trichomonas vaginalis test demonstrates 100% sensitivity for vaginal swabs, endocervical swabs, and ThinPrep samples, with 95.2% sensitivity for urine specimens 2
  • Multiple specimen types are acceptable: vaginal swabs, endocervical swabs, urine, liquid-based cytology specimens, urethral swabs, rectal swabs, and pharyngeal swabs 3
  • Specimens remain stable at room temperature for 7 days (or per manufacturer's recommendations), providing flexibility in transport and processing 3
  • NAAT performs equally well in both symptomatic and asymptomatic patients, making it ideal for screening high-risk populations 2

Alternative Diagnostic Methods (When NAAT Unavailable)

Rapid Antigen Tests

  • The OSOM Trichomonas Rapid Test is the best alternative when NAAT is unavailable, with sensitivity ranging from 62% to 95% compared to culture and NAAT, performing best in symptomatic patients 3, 1
  • Results are available in 15 minutes and do not require live organisms for optimal test performance 4

Culture

  • The InPouch TV culture system allows both immediate smear review by wet mount and subsequent culture, with approximately 70% sensitivity compared to NAAT 3
  • Culture is not widely available and has been largely superseded by NAAT 1

DNA Hybridization Probe

  • The Affirm VP III Assay detects Trichomonas vaginalis but has lower sensitivity than NAAT 3
  • This test is FDA-cleared only for vaginal specimens from symptomatic female patients 3

Methods to Avoid as Primary Diagnostic Tests

Wet Mount Microscopy

  • Wet mount should never be relied upon as the sole diagnostic test due to poor sensitivity of only 40-80%, meaning it will miss 20-60% of true infections 1
  • The test requires live organisms to visualize movement and must be performed within 30 minutes to 2 hours of specimen collection 3, 1
  • If wet mount is negative but clinical suspicion is high (vaginal pH >4.5, risk factors for STIs), more sensitive tests such as NAAT must be used 1

Clinical Algorithm for Diagnosis

  1. For any woman with vaginal discharge and pH >4.5, or patients with STI risk factors: Order NAAT testing on vaginal swab, endocervical swab, or urine 1

  2. If NAAT is unavailable: Use rapid antigen testing (OSOM) for symptomatic patients, which provides results in 15 minutes 1

  3. If microscopy is immediately available: Perform wet mount to check for motile trichomonads, but always confirm negative results with NAAT or rapid antigen testing 1

  4. For screening asymptomatic high-risk populations (multiple sexual partners): Use NAAT, which maintains high sensitivity even in asymptomatic infections 1, 2

Critical Pitfalls to Avoid

  • Never exclude trichomoniasis based on a negative wet mount alone, as sensitivity is only 40-80% 1
  • Do not delay wet mount examination beyond 2 hours, as organisms lose motility and become undetectable 1
  • Remember that up to 50% of trichomoniasis infections are asymptomatic, so absence of symptoms does not exclude infection 1
  • Always evaluate and treat sexual partners simultaneously to prevent reinfection 1

References

Guideline

Tricomoniasis Diagnosis and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.